Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
7.82
Dollar change
-0.20
Percentage change
-2.49
%
IndexRUT P/E- EPS (ttm)-1.72 Insider Own3.62% Shs Outstand29.78M Perf Week-1.76%
Market Cap232.88M Forward P/E- EPS next Y-0.46 Insider Trans0.00% Shs Float28.71M Perf Month-19.63%
Income-46.45M PEG- EPS next Q-0.41 Inst Own25.39% Short Float6.30% Perf Quarter15.85%
Sales0.08M P/S2911.00 EPS this Y17.21% Inst Trans6.71% Short Ratio4.61 Perf Half Y51.26%
Book/sh1.49 P/B5.24 EPS next Y69.42% ROA-48.80% Short Interest1.81M Perf Year-1.76%
Cash/sh2.82 P/C2.77 EPS next 5Y- ROE-91.92% 52W Range4.00 - 10.24 Perf YTD53.94%
Dividend Est.- P/FCF- EPS past 5Y22.80% ROI-102.57% 52W High-23.63% Beta0.21
Dividend TTM- Quick Ratio10.59 Sales past 5Y-22.00% Gross Margin-917.28% 52W Low95.50% ATR (14)0.44
Dividend Ex-Date- Current Ratio10.59 EPS Y/Y TTM-10.98% Oper. Margin-61645.68% RSI (14)41.88 Volatility4.32% 5.03%
Employees49 Debt/Eq0.05 Sales Y/Y TTM-10.00% Profit Margin-57346.91% Recom1.00 Target Price28.00
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q27.61% Payout- Rel Volume0.48 Prev Close8.02
Sales Surprise- EPS Surprise17.99% Sales Q/Q- EarningsMay 13 Avg Volume392.72K Price7.82
SMA20-7.41% SMA50-6.32% SMA20019.61% Trades Volume190,074 Change-2.49%
Date Action Analyst Rating Change Price Target Change
May-14-24Initiated Stephens Overweight $25
Sep-06-23Initiated HSBC Securities Buy $11.60
Feb-21-23Downgrade William Blair Outperform → Mkt Perform
Sep-08-22Initiated Cantor Fitzgerald Overweight $20
Aug-25-22Initiated B. Riley Securities Buy $16
Nov-05-20Initiated Alliance Global Partners Buy $25
Dec-06-17Initiated B. Riley FBR, Inc. Buy $2.75
Oct-23-17Resumed ROTH Capital Buy $6
Sep-14-17Initiated Maxim Group Buy $3
Aug-25-16Initiated ROTH Capital Buy $5
Jun-14-24 08:30AM
Jun-11-24 08:30AM
Jun-10-24 08:30AM
Jun-07-24 07:30AM
May-15-24 08:30AM
06:38PM Loading…
May-14-24 06:38PM
10:24AM
07:46AM
May-13-24 08:30AM
May-07-24 08:00AM
Apr-18-24 08:00AM
Apr-15-24 12:54PM
Apr-01-24 08:00AM
Mar-26-24 07:18AM
Mar-15-24 06:15AM
07:30AM Loading…
Mar-11-24 07:30AM
Feb-26-24 07:30AM
Feb-25-24 01:37PM
Feb-23-24 07:30AM
Jan-02-24 07:30AM
Dec-11-23 08:15AM
07:45AM
Dec-08-23 08:00AM
Nov-06-23 07:30AM
Nov-02-23 04:15PM
09:05AM
Oct-31-23 08:15AM
Oct-04-23 07:30AM
Sep-27-23 09:05AM
Sep-07-23 08:40AM
07:00AM Loading…
Aug-31-23 07:00AM
Aug-21-23 07:00AM
Aug-15-23 09:41AM
Jul-24-23 07:00AM
Jun-26-23 07:00AM
Jun-23-23 08:00AM
Jun-16-23 07:00AM
Jun-14-23 07:00AM
Jun-12-23 07:00AM
Jun-07-23 07:00AM
May-22-23 07:00AM
May-17-23 06:34AM
May-11-23 11:18AM
May-10-23 07:00AM
Apr-28-23 08:00AM
Apr-27-23 10:36AM
Apr-19-23 08:45AM
08:30AM
Apr-03-23 07:00AM
Mar-16-23 08:45AM
Mar-15-23 08:00AM
Feb-27-23 08:00AM
Feb-24-23 04:04PM
Feb-18-23 04:30PM
Feb-14-23 07:30AM
Feb-06-23 07:30AM
Jan-17-23 07:30AM
Jan-12-23 08:00AM
Dec-12-22 08:00AM
Dec-08-22 07:30AM
Nov-10-22 08:15AM
Nov-03-22 09:20AM
Nov-02-22 08:17AM
Oct-31-22 12:12PM
12:00PM
06:00AM
Oct-27-22 07:30AM
Oct-26-22 09:17AM
07:30AM
Oct-25-22 07:30AM
Sep-26-22 07:30AM
Sep-21-22 07:30AM
Sep-08-22 01:50PM
07:00AM
Aug-15-22 10:15AM
Aug-11-22 08:55AM
Aug-09-22 06:25PM
Aug-04-22 07:35AM
May-19-22 09:40AM
Apr-25-22 07:30AM
Apr-19-22 07:30AM
Apr-13-22 03:36PM
Apr-12-22 07:00AM
Apr-11-22 07:37AM
07:17AM
Feb-22-22 08:00AM
Jan-05-22 07:30AM
Dec-14-21 08:00AM
07:45AM
Dec-13-21 07:30AM
Dec-08-21 08:25AM
Nov-12-21 08:15AM
08:00AM
Nov-04-21 09:05AM
09:03AM
Oct-01-21 09:00AM
Sep-28-21 08:00AM
Sep-27-21 08:00AM
Sep-23-21 09:00AM
Sep-20-21 08:36AM
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.